title: H. pylori-Induced Higher C-Reactive Protein in Obese African Americans.
abstract: African Americans are more susceptible to develop insulin resistance, obesity, Type 2 Diabetes, and coronary heart disease (CHD), and systemic inflammation is central to the pathophysiology of these chronic diseases. African Americans are also more likely to contract H. pylori (cagA) infections during their childhood. However, the contribution of H. pylori infection to the degree of overall systemic inflammation in these chronic diseases is not known. Therefore, we studied 46 apparently healthy African Americans, over 40 years of age who were, infected with H. pylori (cagA). These volunteers were assessed at baseline and after treatment with triple regimen drug therapy to eradicate H. pylori. All but 3 subjects were found to be free of this infection by urea breath test (UBT) after the treatment period. No hyperhomocysteinemia was found in these subjects and there were no significant changes in the level of homocysteine (tHcy), folate and B(12); however, CRP levels measured by high sensitivity assay showed a significant (p=0.02) decrease 2 months after the eradication. We further stratified CRP values according to the BMI < 27 and > 27. There was more profound reduction in CRP in the more obese group (i.e., BMI>27) from 54.26 ± 23.67 to 18.73 ± 17.39 mg/l (p=0.01), compared with the leaner subjects in whom CRP decreases from 8.88 ± 6.23 to 4.94 ± 6.21 mg/L (p=0.04), after eradication of the H. pylori (cagA) infection. The level of CRP, however, remained significantly higher in the obese subjects even after the eradication of this infection, indicative of a smaller residual influence of adiposity on CRP. Thus, a major component of systemic inflammation in African Americans may be attributable to chronic H. pylori infection.
authors.affiliation: Department of Nutrition Sciences, University of Alabama at Birmingham Birmingham, AL 35294, USA.
authors.forename: Nuzhat R
authors.initials: NR
authors.lastname: Siddiqui
authors.forename: W Timothy
authors.initials: WT
authors.lastname: Garvey
authors.forename: Mohammad A
authors.initials: MA
authors.lastname: Khaled
references.citation: Heart. 2002 Jul;88(1):43-6
references.pmid: 12067941
references.citation: Ann Epidemiol. 2002 May;12(4):228-36
references.pmid: 11988410
references.citation: Curr Atheroscler Rep. 2002 Mar;4(2):92-8
references.pmid: 11822971
references.citation: Am J Gastroenterol. 1997 Nov;92(11):2025-8
references.pmid: 9362184
references.citation: JAMA. 1997 Jun 11;277(22):1775-81
references.pmid: 9178790
references.citation: Med Hypotheses. 2007;69(1):227-8
references.pmid: 17240082
references.citation: Ren Fail. 2004 May;26(3):279-87
references.pmid: 15354978
references.citation: N Engl J Med. 1999 Jan 14;340(2):115-26
references.pmid: 9887164
references.citation: Int J Obes Relat Metab Disord. 2004 May;28(5):674-9
references.pmid: 14993913
references.citation: Atherosclerosis. 2004 Jan;172(1):199-200
references.pmid: 14709379
references.citation: Circulation. 2001 Apr 3;103(13):1813-8
references.pmid: 11282915
references.citation: BMJ. 1996 Jan 27;312(7025):250-1
references.pmid: 8563608
references.citation: Circulation. 1998 May 5;97(17):1675-9
references.pmid: 9591760
references.citation: Circulation. 1997 Dec 2;96(11):4095-103
references.pmid: 9403635
references.citation: BMJ. 1997 Nov 8;315(7117):1199-201
references.pmid: 9393222
references.citation: Lancet. 2003 Oct 11;362(9391):1231-3
references.pmid: 14568748
references.citation: Dig Dis Sci. 1991 Aug;36(8):1084-8
references.pmid: 1864201
references.citation: BMJ. 1998 Apr 11;316(7138):1130-2
references.pmid: 9552950